Literature DB >> 4336510

Effect of - and -adrenergic stimulation on the uterine motility and adenosine 3'5'-monophosphate level.

I Polacek, E E Daniel.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4336510     DOI： 10.1139/y71-137

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN： 0008-4212            Impact factor:   2.273


× No keyword cloud information.
  7 in total

1.  Role of cyclic adenosine 3',5'-monophosphate in the isoprenaline-induced relaxation of the oestrogen dominated rabbit uterus.

Authors:  B I Nesheim; J B Osnes; I Oye
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  The lack of involvement of cyclic nucleotides in the smooth muscle relaxant action of BRL 34915.

Authors:  J S Gillespie; H Sheng
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

Review 3.  Hormonal and local regulation of uterine activity during parturition: Part II--The prostaglandin and adrenergic systems.

Authors:  M Maggi; E Baldi; T Susini
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

4.  Hormonal interactions in the uterus: inhibition of isoproterenol-induced accumulation of adenosine 3':5'-cyclic monophosphate by oxytocin and prostaglandins.

Authors:  R C Bhalla; B M Sanborn; S G Korenman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-12       Impact factor: 11.205

5.  Does activation of cyclic AMP dependent phosphorylation induced by beta-adrenergic agent control the tone of vascular muscle?

Authors:  M Hirata; H Kuriyama
Journal:  J Physiol       Date:  1980-10       Impact factor: 5.182

6.  An analysis of the actions of prostaglandin E1 on membrane currents and contraction in uterine smooth muscle.

Authors:  A Grosset; J Mironneau
Journal:  J Physiol       Date:  1977-09       Impact factor: 5.182

7.  Refractoriness of the gravid rat uterus to tocolytic and biochemical effects of atrial natriuretic peptide.

Authors:  W Potvin; D R Varma
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.